Medical device licence · 71244 · Class 2
THYROGLOBULIN, ANTIBODY
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed May 4, 2006; ended October 25, 2011. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 71244
- Licence holder
- Biogenex Laboratories Inc.Fremont, CA, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- May 4, 2006
- Ended
- October 25, 2011
- Devices covered
- 4
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- THYROGLOBULIN (CONCENTRATED) (MONOCLONAL)
- THYROGLOBULIN (CONCENTRATED) (POLYCLONAL)
- THYROGLOBULIN (MANUAL) (MONOCLONAL)
- THYROGLOBULIN (MANUAL) (POLYCLONAL)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.